Michelle Kittleson

Dr. Michelle Kittleson, a renowned heart failure expert from Cedars-Sinai, shares her insights on managing heart failure with reduced ejection fraction. She discusses the importance of accurately diagnosing underlying causes and emphasizes personalized medication strategies. The conversation covers the critical role of high-intensity treatment initiation, the efficacy of various drug classes, and the necessity for ongoing patient follow-up. Kittleson also introduces innovative approaches like the 'I Need Help' mnemonic for identifying patients requiring specialized care.

In this insightful discussion, Dr. Michelle Kittleson, a leading expert in heart failure at Cedars-Sinai, unpacks the complexities of heart failure with preserved ejection fraction (HFpEF). She explores key diagnostic strategies like the H2F-PEF score and the challenges of interpreting BNP levels in obese patients. The conversation also highlights the benefits of weight loss and supervised exercise, the role of SGLT2 inhibitors, and nuances in managing comorbidities. Dr. Kittleson provides practical tips for identifying when to refer patients, making this a must-listen for healthcare professionals.

Dr. Michelle Kittleson, a heart failure expert and professor at Cedars-Sinai, discusses the complexities of heart failure with preserved ejection fraction (HFpEF). She breaks down the challenges of diagnosing this condition and introduces the H2F-PEF score for assessment. The conversation covers managing comorbidities, the positive impact of weight loss and exercise, and highlights promising results from GLP-1 receptor agonists. Kittleson emphasizes the importance of recognizing unique patient needs and adjusting treatment strategies accordingly.

Exploring the clinical clues of amyloidosis with Dr. Michelle Kittleson, including diagnostic challenges and treatment options. Delving into the intricacies of cardiac amyloidosis, diagnostic clues, and advancements in therapy. Discussing the challenges of diagnosing and managing medical conditions, emphasizing the importance of clinical suspicion and individualized therapies.

In this engaging discussion, Dr. Michelle Kittleson, a leading heart failure expert at Cedars-Sinai, and Dr. Jason Feinman, a cardiology fellow, delve into the complexities of advanced heart therapies. They explore the signs of end-stage heart failure, the importance of a multidisciplinary evaluation team, and the balancing act between LVADs and heart transplants. Dr. Kittleson shares insights on patient selection, ethical considerations, and future advancements in heart failure care, making it a must-listen for aspiring cardiologists.